MERTK and breast carcinoma: In this regard, it is interesting that MerTK is highly expressed in breast adenocarcinoma but lowly expressed in common breast carcinoma, implying that the beneficial versus detrimental functions of MerTK mediated by efferocytosis may be cancer subtype-specific in impact.